Physician

Edward Hunt Wood, MD

According to 2025 Medicare claims, Edward Wood, MD (NPI: 1487099412) practices ophthalmology in the Killeen-Temple, TX market, with the plurality of this provider's patient population coming from Bell, TX. This provider's primary affiliated billing organization is AUSTIN RETINA ASSOCIATES PLLC (NPI: 1114999828; TIN: 74-2034080) and primary practice location at 76543-5917. Wood is affiliated with the University Healthcare Alliance DBA Stanford Medicine Partners (ACO ID: A4733), participating under the MSSP model.

Wood's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,113 traditional Medicare patients, billed 23,348 HCPCS/CPT codes, and received $3,403,486 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 300 prescription claims across 128 beneficiaries totaling $11,975 in drug costs, led by Difluprednate (Difluprednate). Open Payments data shows 53 records totaling $36,653. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $5,879 to $3,403,486. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $960 and ending at $11,975. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.4M2017 Medicare payment: $5,879 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $17,577 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $18,219 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $8,067 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $49,737 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $929,585 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,495,459 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,403,486 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20174455$5,879
2018118193$17,577
201984153$18,219
202047133$8,067
2021202705$49,737
20225313,817$929,585
20231,00212,337$2,495,459
20241,11323,348$3,403,486

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$13K$25K2016 Drug cost: $960 (USD; Tot_Drug_Cst)2017 Drug cost: $12,509 (USD; Tot_Drug_Cst)2018 Drug cost: $25,419 (USD; Tot_Drug_Cst)2019 Drug cost: $16,248 (USD; Tot_Drug_Cst)2020 Drug cost: $1,157 (USD; Tot_Drug_Cst)2021 Drug cost: $3,478 (USD; Tot_Drug_Cst)2022 Drug cost: $8,831 (USD; Tot_Drug_Cst)2023 Drug cost: $11,708 (USD; Tot_Drug_Cst)2024 Drug cost: $11,975 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R12$960
201796217$12,509
2018169463$25,419
2019118319$16,248
2020N/R23$1,157
20213072$3,478
202270193$8,831
2023104239$11,708
2024128300$11,975

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye324359$118
67028Injection of drug into eye4871,621$91
92014Established patient complete exam of visual system388445$82
92134Imaging of retina8942,248$28
92250Photography of the retina316440$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DifluprednateDifluprednate281,016$2,487
Bromfenac SodiumBromfenac Sodium18534$2,270
Prednisolone AcetatePrednisolone Acetate281,194$1,120
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha972,147$1,021
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat252,315$250

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.53$36,653Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Edward Hunt Wood, MD?

Tedicare shows public-source Medicare data for Edward Hunt Wood, MD (NPI 1487099412), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Edward Hunt Wood, MD have ACO affiliation data?

Edward Hunt Wood, MD is shown with ACO affiliation data for University Healthcare Alliance DBA Stanford Medicine Partners (MSSP, ACO ID A4733).

What billing organization is linked to Edward Hunt Wood, MD?

Edward Hunt Wood, MD is linked to AUSTIN RETINA ASSOCIATES PLLC (billing NPI 1114999828) in the available physician profile data.

Does Edward Hunt Wood, MD have Open Payments data?

Edward Hunt Wood, MD has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.